# Study Details | NCT07552974 | CBD Supplementation in Brazilian Jiu-Jitsu Athletes > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/nct07552974-cbd-supplementation-brazilian-jiu-jitsu-athletes-study/ > **Published:** 2026-05-19T15:25:05-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:14:47-04:00 > **Clinical Summary:** Clinical analysis of NCT07552974 examining CBD supplementation in Brazilian jiu-jitsu athletes for recovery and performance outcomes. --- CED Clinical Relevance  #60Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Performance And RecoveryCbdAnti-InflammatoryAthletic MedicineEvidence In Progress Why This Matters Performance-enhancing supplement claims in combat sports drive both athlete demand and regulatory scrutiny. This trial tests whether CBD—increasingly used off-label for recovery and anxiety in high-contact athletics—has measurable effects on injury incidence, performance metrics, or stress markers in a sport where both CNS effects and anti-inflammatory properties would theoretically matter. Clinical Summary This is an active clinical trial (NCT07552974) investigating CBD supplementation in Brazilian Jiu-Jitsu athletes, likely examining effects on injury prevention, recovery, anxiety, or performance outcomes. The rationale likely centers on CBD’s putative anti-inflammatory and anxiolytic properties, and its legal status as a non-prohibited supplement in most sports governing bodies. The trial design, enrollment size, dosing regimen, and primary endpoints are not detailed in the available summary, so conclusions about methodology strength or clinical relevance require access to the full protocol. Dr. Caplan’s Take “*We need to see the actual data before we know if this moves the needle.* CBD in athletes is a plausible hypothesis—inflammation and anxiety are real in combat sports—but the evidence base for performance or injury outcomes in this population remains thin. The trial is the right move; anecdotal enthusiasm from athletes is not.” Clinical Perspective 🧠 Clinicians working with combat athletes should not counsel CBD for injury prevention or performance until results are published and peer-reviewed. If positive, look carefully at effect sizes, dropout rates, and whether outcomes are clinically meaningful (not just statistically significant). Ask patients about dose, product source/third-party testing, and drug-test implications in their sport, since [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) may contain trace THC or other cannabinoids. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Study%20Details%20%7C%20NCT07552974%20%7C%20CBD%20Supplementation%20in%20Brazilian%20Jiu-Jitsu%20Athlete...%20%40drcaplan&url=https%3A//clinicaltrials.gov/study/NCT07552974)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//clinicaltrials.gov/study/NCT07552974)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Study%20Details%20%7C%20NCT07552974%20%7C%20CBD%20Supplementation%20in%20Brazilian%20Jiu-Jitsu%20Athlete...%20--%20via%20%40drcaplan.bsky.social%20https%3A//clinicaltrials.gov/study/NCT07552974)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://clinicaltrials.gov/study/NCT07552974](https://clinicaltrials.gov/study/NCT07552974) Table of Contents - [FAQ](#FAQ)[What is CED Clinical Relevance #60?](#What_is_CED_Clinical_Relevance_60) - [What topics are covered in this article?](#What_topics_are_covered_in_this_article) - [What is CBD and how does it relate to this article?](#What_is_CBD_and_how_does_it_relate_to_this_article) - [Why is this marked as “Evidence in Progress”?](#Why_is_this_marked_as_Evidence_in_Progress) - [What should clinicians do with this information?](#What_should_clinicians_do_with_this_information) - [Related](#Related) ## FAQ #### What is CED Clinical Relevance #60? This is a notable clinical interest alert highlighting emerging findings or policy developments in cannabis and [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) worth monitoring closely. It represents the latest update in the CED Clinic’s series of clinical relevance reports. #### What topics are covered in this article? The article focuses on cannabis news related to performance and recovery, CBD, [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/), athletic medicine, and evidence that is currently in progress. These topics represent key areas of clinical interest in [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/). #### What is CBD and how does it relate to this article? CBD (cannabidiol) is a non-intoxicating compound from cannabis highlighted as a subject of clinical interest. The article examines its potential anti-inflammatory properties and applications in athletic medicine and performance recovery. #### Why is this marked as “Evidence in Progress”? This tag indicates that the [clinical evidence](https://cedclinic.com/academic-partnerships-cannabis-research/) surrounding these cannabis-related topics is still being developed and researched. It suggests that while findings are emerging, more studies are needed to establish definitive clinical applications. #### What should clinicians do with this information? Clinicians should monitor this emerging research on cannabis and CBD for potential clinical applications in their practice, particularly regarding [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) and athletic medicine. The findings are important to track as evidence continues to develop. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).